Correction MAR label – SelectImmune Pharma’s CEO recruited to new position
The correction refers to the MAR label. This press release should be without the MAR label. Selectimmune Pharma’s CEO Ann Gidner will leave SelectImmune Pharma, having accepted an offer from a non-competing Life-Science company. Ann Gidner will remain in the CEO role during the notice period of one month. The board has initiated the recruitment of a new CEO for the company.”We are grateful for the contributions of Ms Gidner and wish her all the best in her next position,” says Catharina Svanborg, Chairman of the board, SelectImmune Pharma. For more information, please contact: